Details of the Drug Formulaction

General Information of Drug Formulation (ID: F06779)

• Formulation Name: Doxazosin 4 mg tablet
• Company: Aidarex Pharmaceuticals; Aphena Pharma Solutions-Tennessee; Mylan Pharamceuticals; NCS HealthCare of KY, Inc dba Vangard Labs; PD-Rx Pharmaceuticals; Physicians Total Care

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Doxazosin	(DM9PLRH)	Benign prostatic hyperplasia	GA90	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
FD&C blue no. 2	(E00446)	2723854	Colorant
Magnesium stearate	(E00208)	11177	lubricant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant